« Previous
Next »
Psychoneuroendocrinology
Volume 34, Issue 8
, Pages 1257-1262
, September 2009
Circulating endocannabinoids and N-acyl ethanolamines are differentially regulated in major depression and following exposure to social stress
References
- . Diagnostic and Statistical Manual of Mental Disorders. 4th ed.. Washington, DC: American Psychiatric Association; 1994;
- . Influence of fatty acid ethanolamides and delta9-tetrahydrocannabinol on cytokine and arachidonate release by mononuclear cells. Eur. J. Pharmacol. 1997;330:231–240
- . Endogenous cannabinoids: structure and metabolism. J. Neuroendocrinol. 2008;20(Suppl. 1):1–9
- . Endocrinology of the stress response. Annu. Rev. Physiol. 2005;67:259–284
- . Efficacy and safety of the weight-loss drug rimonabant: a meta-analysis of randomised trials. Lancet. 2007;370:1706–1713
- . The Depression Interview and Structured Hamilton (DISH): rationale, development, characteristics, and clinical validity. Psychosom. Med. 2002;64:897–905
- . Oleoylethanolamide regulates feeding and body weight through activation of the nuclear receptor PPAR-alpha. Nature. 2003;425:90–93
- . Regulation of endocannabinoid signaling by stress: implications for stress-related affective disorders. Neurosci. Biobehav. Rev. 2008;32:1152–1160
- . Is there a role for the endocannabinoid system in the etiology and treatment of melancholic depression?. Behav. Pharmacol. 2005;16:333–352
- . Impairments in endocannabinoid signaling and depressive illness. JAMA. 2009;301:1165–1166
- . Serum endocannabinoid content is altered in females with depressive disorders: a preliminary report. Pharmacopsychiatry. 2008;41:48–53
- . The cannabinoid receptors. Prostaglandins Other Lipid Mediat. 2002;68(69):619–631
- . Inhibition of exocytotic noradrenaline release by presynaptic cannabinoid CB1 receptors on peripheral sympathetic nerves. Br. J. Pharmacol. 1996;118:2023–2028
- . Persistent high cortisol responses to repeated psychological stress in a subpopulation of healthy men. Psychosom. Med. 1995;57:468–474
- . The nuclear receptor peroxisome proliferator-activated receptor-alpha mediates the anti-inflammatory actions of palmitoylethanolamide. Mol. Pharmacol. 2005;67:15–19
- . Cannabinoid receptors and endocannabinoids: evidence for new players. AAPS J. 2006;8:E298–R306
- . Endogenous cannabinoids in the brain and peripheral tissues: regulation of their levels and control of food intake. Int. J. Obes. 2006;30(Suppl. 1):S7–S12
- . Role and regulation of acylethanolamides in energy balance: focus on adipocytes and beta-cells. Br. J. Pharmacol. 2007;152:676–690
- . Clinical depression and regulation of the inflammatory response during acute stress. Psychosom. Med. 2005;67:679–687
- . Increased stress-induced inflammatory responses in male patients with major depression and increased early life stress. Am. J. Psychiatry. 2006;163:1630–1633
- . Cytokine-effects on glucocorticoid receptor function: relevance to glucocorticoid resistance and the pathophysiology and treatment of major depression. Brain Behav. Immun. 2007;21:9–19
- . The CES-D scale: a self-report depression scale for research in the general population. J. Appl. Psychol. Meas. 1977;1:385–401
- . Endocannabinoids and the haematological system. Br. J. Pharmacol. 2007;152:671–675
- . The NIMH diagnostic interview schedule: its history, characteristics, and validity. Arch. Gen. Psychiatry. 1981;38:381–389
- . Anandamide biosynthesis catalyzed by the phosphodiesterase GDE1 and detection of glycerophospho-N-acyl ethanolamine precursors in mouse brain. J. Biol. Chem. 2008;283:9341–9349
- . Utility of a new procedure for diagnosing mental disorders in primary care: the PRIME-MD 1000 study. JAMA. 1994;272:1749–1756
- . Role of the endocannabinoid system in regulation of the hypothalamic–pituitary–adrenocortical axis. Prog. Brain Res. 2008;170:397–432
PII: S0306-4530(09)00096-1
doi: 10.1016/j.psyneuen.2009.03.013
© 2009 Elsevier Ltd. All rights reserved.
« Previous
Next »
Psychoneuroendocrinology
Volume 34, Issue 8
, Pages 1257-1262
, September 2009
